• State and Prospects of Pharmacoeconomics Training in Ukraine

    Nov 1, 2015, 00:00
  • Descriptive Evalaution of Characteristics of Patients Diagnosed with Relapsing Remitting Multiple Sclerosis and Taking Disease Modifying Agents

    Nov 1, 2015, 00:00
  • Data Mining Based On Real World Data In Chronic Kidney Disease Patients Not On Dialysis- The Key Role Of Early Hemoglobin Levels Control

    Nov 1, 2015, 00:00
  • Hospitalization Expenses Analysis Of Chinese Stroke Patients With Urban Employee Basic Medical Insurance

    Nov 1, 2015, 00:00
  • Biopharma Intervention Valuation- An Evidence-Based Appraisal Framework for Oncology Drugs

    Nov 1, 2015, 00:00
  • Burden of Spinal Diseases- Results From Register Study In Sweden

    Nov 1, 2015, 00:00
  • Does One Size Fit All? - Challenges Faced when Adapting Translations for an Electronic Platform

    Nov 1, 2015, 00:00
  • Choice of Antithrombotic Drug in non-Valvular Atrial Fibrillation Patients in Real-World Practice

    Nov 1, 2015, 00:00
  • Cost-Effectiveness of Ledipasvir/Sofosbuvir for the Treatment of Genotype 1 Or 4 Chronic Hepatitis C in England and Wales

    Nov 1, 2015, 00:00
  • Qualitative Assessment of Societal Preferences for Market Access of Cancer Drugs

    Nov 1, 2015, 00:00
  • Eficacia Y Seguridad Del Uso Del Cetuximab En Pacientes Con Cancer Colorrectal Metastásico

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Analysis Of Capsule Endoscopy Using For Diagnosing Small Bowel Crohn’s Disease

    Nov 1, 2015, 00:00
  • The Power of the Patient Voi Formalising Qualitative Data in the Drug Approval Process

    Nov 1, 2015, 00:00
  • Quality of Life Among Hiv Patients- Results from the Ianua Clinical Trial

    Nov 1, 2015, 00:00
  • The Survey of Physicians’ Satisfaction of Implementing Interventions for Changing Prescribing Behavior Toward Rational Medicine Use-2014

    Nov 1, 2015, 00:00
  • Adherence of hiv patients switching to emtricitabina+tenofovir disoproxil+rilpivirin. Real world evidence from italian administrative databases

    Nov 1, 2015, 00:00
  • Effectiveness Of Supporting Informal Caregivers Of People With Dementia- A Systematic Review

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Of Directly Mailed Fobt Kits To Previous Responders Being Recalled For Screening

    Nov 1, 2015, 00:00
  • Aligning Patient Centred Evidence Generation Across the Drug Development Lifecycle

    Nov 1, 2015, 00:00
  • Costo De Tuberculosis En Los Establecimientos De Salud Del Perú

    Nov 1, 2015, 00:00
  • Inadequate Treatment of Post-Surgical Pain May Result in Extended Hospitalization Period

    Nov 1, 2015, 00:00
  • Treatment Patterns Among Front-Line Glioblastoma Patients In Five European Countries

    Nov 1, 2015, 00:00
  • Costo - efectividad de la combinacion de glicopirronio/indacaterol vs. Salmeterol/ fluticasona (combinacion de dosis fija – cdf) en el manejo de los pacientes con enfermedad pulmonar obstructiva cronica (epoc) en colombia (sur américa)

    Nov 1, 2015, 00:00
  • Romania’s New HTA System- What Progress have Innovative Drugs Made under the Points-Based System So Far?

    Nov 1, 2015, 00:00
  • Humanistic Burden of Chronic Spontaneous Urticaria in Comparison to Psoriasis- European Perspective

    Nov 1, 2015, 00:00
  • Network Meta-Analysis Of Multiple Outcomes Incorporating Dose-Related Constraints- Application To Overactive Bladder Syndrome

    Nov 1, 2015, 00:00
  • High-Dose Inactivated Influenza Vaccine can Reduce Costs and Improve Outcomes Compared to Standard-Dose Inactivated Influenza Vaccine in Canadian Seniors

    Nov 1, 2015, 00:00
  • Weight Loss Treatment Patterns in Mexico

    Nov 1, 2015, 00:00
  • Cost-Utility Analysis Of Apixaban In The Acute Treatment And Prevention Of Venous Thromboembolism In France

    Nov 1, 2015, 00:00
  • Overview of Generics Policies and Penetration in Japan

    Nov 1, 2015, 00:00
  • Children’s Medication In The Nordic Countries – Survey on National Administrative Register Data

    Nov 1, 2015, 00:00
  • Budget Impact Analysis Of Phased Radiofrequency (Rf) Catheter Ablation System In The Treatment Of Atrial Fibrillation (Af) In Turkey

    Nov 1, 2015, 00:00
  • Inclusion Of A Novel Ibs Blood Panel For Diagnosing Diarrhea Predominant Irritable Bowel Syndrome (Ibs-D)- A Uk Perspective

    Nov 1, 2015, 00:00
  • Higher Accuracy Of Blood Glucose Monitoring Systems In Type 2 Insulin Treated Diabetic Patients In Spain- Clinical And Economic Impact

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Analysis Of Obinutuzumab/Chlorambucil Vs Rituximab/Chlorambucil In Treatment Of Chronic Lymphocytic Leukemia

    Nov 1, 2015, 00:00
  • Effect of Patient-Education on Health-Related Quality of Life of Diabetic Foot Ulcer Patients In A Tertiarycare Hospital

    Nov 1, 2015, 00:00
  • Budget Impact Analysis In The Uk Setting – Know Your Audience

    Nov 1, 2015, 00:00
  • Avaliação De Tecnologias No Tratamento Da Depressão Maior- Overview Sobre A Eficácia E Segurança Da Duloxetina, Venlafaxina E Trazodona Comparados À Fluoxetina

    Nov 1, 2015, 00:00
  • Survey on Romanian Hospitals Financing Reveals Major Dysfunctions In Covering Drug Treatment During Hospitalization

    Nov 1, 2015, 00:00
  • Fixed Combination Netupitant And Palonosetron Is A Cost-Effective Intervention For The Prevention Of Chemotherapy-Induced Nausea And Vomiting In The Uk

    Nov 1, 2015, 00:00
  • The Economic Consequences of the use of Antidepressants in Belgium- Prescribing Behavior and Misuse of Antidepressants

    Nov 1, 2015, 00:00
  • Economic Assessment of Eribulin Against Treatment of Physician’s Choice (Tpc) in Taiwan

    Nov 1, 2015, 00:00
  • Quality of Life in Patients After Total Hip Replacement

    Nov 1, 2015, 00:00
  • Health Technological Supports to Detect Medication Errors- The Saniarp Case-Study

    Nov 1, 2015, 00:00
  • Factores Pronosticos De Sobrevida En La Neoplasia Trofoblastica Gestacional

    Nov 1, 2015, 00:00
  • Improving Patient Quality of Life By Verifying And Enhancing Quality of Orthopaedic And Prosthetic Medical Devices

    Nov 1, 2015, 00:00
  • Análisis de Costo Efectividad y Costo Utilidad de Rituximab Como Tratamiento en Pacientes Con Artritis Reumatoide, Ante el Fallo o Intolerancia en Primera Línea de un Anti-Tnf, en el Contexto Venezolano

    Nov 1, 2015, 00:00
  • Economic Evaluation of Chondroitin Sulfate and Non-Steroidal Antiinflammatory Drugs for The Treatment of Osteoarthritis

    Nov 1, 2015, 00:00
  • Pharmacovigilance Of Anti-Neoplastic Agents In A Developing Country—A Report Through A Spontaneous Reporting Contineous Monitoring System

    Nov 1, 2015, 00:00
  • Nub Status – An Analysis Comparing Results of 2015 Vs. 2014 - Leading Therapeutic Areas Confirmed

    Nov 1, 2015, 00:00
  • How to Calculate Value of Information in Seconds Using ‘Savi’, the Sheffield Accelerated Value of Information Web App

    Nov 1, 2015, 00:00
  • Number of Osteoporosis Patients with Pathological Fractures By Gender in Outpatient Care in the Light of Physiotherapy Care in Hungary

    Nov 1, 2015, 00:00
  • Disease Burden And Costs Associated With Urinary Tract Infections In Type 2 Diabetes Mellitus Patients- An Analysis Based On A Large Sample Of 456,586 German Patients

    Nov 1, 2015, 00:00
  • Off-Label Use of Intravenous Immunoglogulins (IVIGS)- Funding Mechanisms in France, Germany, Italy, Spain and the United Kingdom (EU5)

    Nov 1, 2015, 00:00
  • Hurdles That Impede Economic Evaluations of Health Care Interventions Tested By General Practitioners In Flanders- A Qualitative Study

    Nov 1, 2015, 00:00
  • A Cost Effectiveness Analysis of Nivolumab Compared to Ipilimumab for the Treatment of Braf Wild-Type Advanced Melanoma in Australia

    Nov 1, 2015, 00:00
  • Development of Hospital-Based Hta Unit Processes In The Czech Hospital Environment

    Nov 1, 2015, 00:00
  • Cart Analysis As A Tool To Determine Optimal Treatment Intensification Time In Diabetes

    Nov 1, 2015, 00:00
  • Cost-Utility Analysis of Apremilast for The Treatment of Moderate to Severe Psoriasis In Spain

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Analysis of Exenatide Once-Weekly Versus Dulaglutide, Liraglutide and Lixisenatide for the Treatment of Type 2 Diabetes Mellitus- An Analysis from the UK NHS Perspective

    Nov 1, 2015, 00:00
  • Longitudinal Modeling Of The Relationship Between Lisdexamfetamine Dimesylate And Health-Related Quality Of Life In Adults With Moderate To Severe Binge Eating Disorder

    Nov 1, 2015, 00:00
  • Health Economic Programming Using Royston-Parmar “Hazard Rate” Models- Providing Flexibility and Speed for Event Modelling In Cohort and Des Models

    Nov 1, 2015, 00:00
  • Scoping Review of Publicly Available Performance Information in Argentina, Chile and Colombia

    Nov 1, 2015, 00:00
  • Influence of Some Factors on The Morphological Structure of Spermatozoa In Straight Intestine During Forensic - Medical Examination of Sodomy

    Nov 1, 2015, 00:00
  • Economic Analysis Of Evicel® Compared With Standard Of Care For Dural Closure In Elective Cranial Surgery- A United Kingdom Hospital Perspective

    Nov 1, 2015, 00:00
  • Investigation of the Living and its Impact to the Pregnants

    Nov 1, 2015, 00:00
  • The Association of Waist Circumference with Glycaemic Control in Diabetic Patients in an Asian Population

    Nov 1, 2015, 00:00
  • Resource Use And Direct Costs For Managing Hcv Genotype 1 Patients In Colombia

    Nov 1, 2015, 00:00
  • Costs for Diabetic Patients Receiving Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in US Medicare and Commercial Insurance Plans

    Nov 1, 2015, 00:00
  • Clinical and Economic Burden of Prostate Cancer

    Nov 1, 2015, 00:00
  • Social Utility Values for Pemphigus Vulgaris and Foliaceus- A Composite Time Trade-Off Study

    Nov 1, 2015, 00:00
  • Medical Devices- Innovative Models To Access The Market Leveraging On Shared Infrastructure Among Payers And Pharmaceutical Companies

    Nov 1, 2015, 00:00
  • A Network Meta-Analysis (NMA) to Assess the Longer-Term Relative Efficacy of Canagliflozin in Patients with Type 2 Diabetes Inadequately Controlled on Metformin

    Nov 1, 2015, 00:00
  • Comparative Effectiveness of Ticagrelor Vs. Prasugrel in Patients with Acute Coronary Syndrome

    Nov 1, 2015, 00:00
  • Benchmarking Health Technology Assessment (Hta) Agencies for Setting Standards on Pharmacoeconomic, Pricing, Evidence, and General Submission Requirements- development of a Multidimensional Rating Scale

    Nov 1, 2015, 00:00
  • Study Of Acute Lower Respiratory Tract Infections In Children Of Age Group 1 Month To 5 Years

    Nov 1, 2015, 00:00
  • Costs Of Cardiovascular (Cv) Events In The United Kingdom (Uk) Using Real-World Data

    Nov 1, 2015, 00:00
  • Development of A Screening Tool to Support Identification of Patients With Secondary Progressive Multiple Sclerosis (Spms)

    Nov 1, 2015, 00:00
  • Using Tangent Line Segments to Determine Statistical Differences between Survival Curves at a Single Point in Time

    Nov 1, 2015, 00:00
  • High-Cost Oncologic Medication Access- Why Is Latin America Falling Behind? Case Study In Non-Small Cell Lung Cancer (NSCLC)

    Nov 1, 2015, 00:00
  • Effect of Persistence of Biologic Therapy on Long Term Direct Healthcare Costs of Psoriatic Arthritis In Russian Plaque Psoriasis Patients

    Nov 1, 2015, 00:00
  • Diabetes Duration and Severity and Labour Market Outcomes In Mexico

    Nov 1, 2015, 00:00
  • A Systematic Review of Model-Based Economic Evaluations of Drug Substitution Therapies in Maintenance Treatment of Non-Prescription Opioid Dependence

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Analysis of Romiplostim for The Treatment of Adult Chronic Immune Thrombocytopenic Purpura (Itp) In Brazil

    Nov 1, 2015, 00:00
  • Reversal of Neuromuscular Blockade- A Discrete Event Simulation Model of Clinical and Operating Room Efficiency Outcomes of Sugammadex Versus Neostigmine In Canada

    Nov 1, 2015, 00:00
  • A Systematic Literature Review On The Impact Of Therapeutic Interventions On Quality Of Life In Systolic Hf Randomized Clinical Trials

    Nov 1, 2015, 00:00
  • Cost-effectiveness of Ranibizumab Vs. Dexamethasone Implant In Diabetic Macular Edema

    Nov 1, 2015, 00:00
  • Resistência Antimicrobiana- Identificação Das Pesquisas Brasileiras Fomentadas Para Suporte À Gestão No País

    Nov 1, 2015, 00:00
  • Costo-Utilidad de Un Esquema Inicial de Tratamiento Con Tofacitinib Comparado Con Terapia Biologica Anti-Tnf en Pacientes Adultos Con Artritis Reumatoide Que Han Presentado Respuesta Inadecuada a Metotrexato en Venezuela

    Nov 1, 2015, 00:00
  • Assessing the Translatability of the Term “Distressed”

    Nov 1, 2015, 00:00
  • Cost Effectiveness of Triple Therapy for Adults Patients with Genotype 1 Chronic Hepatitis C

    Nov 1, 2015, 00:00
  • Study On Cost-Effectiveness Analysis For Multiple Myeloma Treatment- A Systematic Review Of Literature From 2004-2014

    Nov 1, 2015, 00:00
  • Making Collaborative Relative Effectiveness Assessments Relevant- Experience of 4 Eunethta Pilots Across Pharmaceuticals and Medical Devices

    Nov 1, 2015, 00:00
  • Descriptive Epidemiology And Treatment Strategies Used In Multiply Myeloma In The Slovak Republic. Results From The Cross-Sectional Survey In The Haematology-Oncological Centers

    Nov 1, 2015, 00:00
  • Cost-Savings And Cost-Utility Of An Ehr System Smartphone App In A Trauma Intensive Care Unit

    Nov 1, 2015, 00:00
  • Assessing The Potential for Tiered Pricing of High Priced Therapies Within Argentina, Columbia, Mexico, Indonesia, and Thailand

    Nov 1, 2015, 00:00
  • Economic Burdens of the Top 10 Cancers During 2003-2012 in Taiwan

    Nov 1, 2015, 00:00
  • Modelling The Likely Impact of The Obesity Epidemic on Mortality And Cause of Death In Older Adults

    Nov 1, 2015, 00:00
  • Performance of Drg-Based Reimbursement Policy In National Health Insurance - Eight Years’ Experiences

    Nov 1, 2015, 00:00
  • Do Socioeconomic Inequalities Impact The Social Cost Of Chronic Kidney Disease In Italy?

    Nov 1, 2015, 00:00
  • Estimating the Monetary Value of Relief of Tennis Elbow- A Contingent Valuation Study of Willingness-To-Pay

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Analysis Of Continuous Remote Monitoring Of Heart Failure Patients With Cardiac Electronic Implantable Device

    Nov 1, 2015, 00:00
  • Physicians’ Prescribing Pattern For Tuberculosis- Evidences From Community Pharmacies In Punjab, Pakistan

    Nov 1, 2015, 00:00
  • Comparative Effectiveness of Triple Antihypertensive Combination Therapy for Patients with Resistant Hypertension In Taiwan

    Nov 1, 2015, 00:00
  • Pharmacy Cost Differences Associated with the Initiation of Exenatide Once-Weekly Compared to Liraglutide Once-Daily

    Nov 1, 2015, 00:00
  • Progressive Disease Does Not Impact Hrqol In Patients Receiving Nivolumab For The Treatment Of Unresectable Or Metastatic Melanoma

    Nov 1, 2015, 00:00
  • Health Care Coverage Through Private Health Insurance

    Nov 1, 2015, 00:00
  • Cost-Effectiveness of Transcatheter Aortic Valve Replacement- Current Decision-Analytic Models and Future Opportunities

    Nov 1, 2015, 00:00
  • Evaluation of Inhaler Technique Mastery and Handling Errors With Spiromax®, Easyhaler®, And Turbuhaler® Devices (Finhaler)

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Analysis of Intravitreal Aflibercept In Diabetic Macular Oedema In Sweden

    Nov 1, 2015, 00:00
  • A Microcosting Study Of Radiation Therapy In Localized Prostate Cancer Patients In A Hungarian Tertiary Oncology Center

    Nov 1, 2015, 00:00
  • Budget Impact Analysis of Introducing Lisdexamfetamine Dimesylate for the Treatment of Binge Eating Disorder in the United States

    Nov 1, 2015, 00:00
  • The Budget Impact of Orphan Drugs In The Us and Canada- A 2007-2013 Midas Sales Data Analysis

    Nov 1, 2015, 00:00
  • Increase Arv Access for Plwha In Dominican Republic Through The Transition From Vertical Supply System to An Integrated National Pharmaceutical System

    Nov 1, 2015, 00:00
  • Assessment of Who/Inrud Core Drug Use Indicators in two Tertiary Care Hospitals of Bahawalpur, Punjab, Pakistan

    Nov 1, 2015, 00:00
  • Adherence With Therapeutic Guidelines In The Treatment Of Venous Thromboembolism And Pulmonary Embolism In Clinical Practice. Findings From The Victor Study

    Nov 1, 2015, 00:00
  • Assessment of Iron Deficiency And Anemia In Pregnant Women In Fran An Observational Study

    Nov 1, 2015, 00:00
  • Medical Costs And Resources Consumption In Patients With Atrial Fibrillation- An Italian Observational Study

    Nov 1, 2015, 00:00
  • A Review of Guidelines And Approaches to Performance-Based Risk-Sharing Agreements Across The Uk, Italy And The Netherlands

    Nov 1, 2015, 00:00
  • Impact Of A Novel Ibs Diagnostic Blood Panel For Mexico- Cost Implications To The Mexican Private Practice For Diarrhea Predominant Irritable Bowel Syndrome (Ibs-D)

    Nov 1, 2015, 00:00
  • The Cost of Patients With Relapsing-Remitting Multiple Sclerosis Who Develop Neutralizing Antibodies While Treated With Interferon Beta

    Nov 1, 2015, 00:00
  • Cognitive Symptoms In Major Depressive Disorder And Their Italian Psychiatrists’ Perception

    Nov 1, 2015, 00:00
  • Fluticasone Propionate Versus Budesonide or Beclomethasone As Monotherapy Treatment for Asthma Patients - A Systematic Review

    Nov 1, 2015, 00:00
  • Patterns Of Use Of Tests To Monitor Disease Activity Among Patients Currently Treated For Relapsing Remitting Multiple Sclerosis (Rrms) In Europe

    Nov 1, 2015, 00:00
  • Correlation Between Equation For Estimating Glomerular Filtration Rate- Chronic Kidney Disease Epidemiology Collaboration -Ckd -Epi, Cockcroft-Gault -Cg- And Modification Of Diet And Renal Disease –Mdrd4- In Colombia

    Nov 1, 2015, 00:00
  • Using Decision Making Clinical Scenarios to Appraise Preferences and Value Judgments in Health Technology Assessment (Hta)

    Nov 1, 2015, 00:00
  • Cost-Effectiveness of Treatments for Wet Age-Related Macular Degeneration (Wamd) In The Netherlands, The Case of Intravitreal Aflibercept (Ivt-Afl) and Ranibizumab

    Nov 1, 2015, 00:00
  • Geographical Disparities in Colon Cancer Care in Europe- Implications for Access to Innovative Medicines Via the UK Cancer Drugs Fund

    Nov 1, 2015, 00:00
  • Do Free Medications Improve Observance Among Diabetic Patients?

    Nov 1, 2015, 00:00
  • La Canasta Basica de Medicamentos Como Estrategia Para Mejorar el Acceso y Costo de Los Medicamentos en Panama

    Nov 1, 2015, 00:00
  • Acromegaly Patients with Inadequate Response to Maximum Dose Octreotide-Lar Who Progress to Treatment with Pegvisomant- Economic Evaluation and Incremental Budget Impact Analysis from the Public Perspective to São Paulo State

    Nov 1, 2015, 00:00
  • Economic Analysis Of Evarrest® Sealant Matrix Compared With Standard Of Care In Severe Soft Tissue Surgical Bleeding- An Italian Hospital Perspective

    Nov 1, 2015, 00:00
  • External And Internal Reference Pricing As Cost Containment Measures In Bulgaria

    Nov 1, 2015, 00:00
  • Current Challenges and Opportunities to Market Access in Brazil, Argentina, Mexico and Colombia

    Nov 1, 2015, 00:00
  • A Scotland Based Cost-Effectiveness Analysis Of Idelalisib (Zydelig®) In Combination With Rituximab For The Treatment Of Adults With Chronic Lymphocytic Leukaemia Cll)

    Nov 1, 2015, 00:00
  • Health-Economic Comparison of a Gnrh-Antagonist (Degarelix) Vs. Gnrh-Agonists Considering the Number-Needed-to-Treat to Avoid Cardiovascular Events

    Nov 1, 2015, 00:00
  • Thrombectomy in the treatment of acute ischemic stroke- what effects do methodological differences in trial design have on comparability of outcomes?

    Nov 1, 2015, 00:00
  • The Indirect Costs of Types 1 Diabetes Mellitus Associated with Absenteeism in Poland in 2013

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Analysis Of Tobacco Dependence Treatment In The Czech Republic

    Nov 1, 2015, 00:00
  • Benefícios Materiais Como Incentivo Para Redução de Abandono de Tratamento de Tuberculose em Pessoas Vivendo em Situação de Rua- Revisão de Análises Econômicas

    Nov 1, 2015, 00:00
  • Real-World Data on Multiple Comorbidities Among Patients With Hepatitis C- Considerations for Patient Care And Prognosis

    Nov 1, 2015, 00:00
  • Patterns of Utilization and Cost of Prostacylins for Pulmonary Arterial Hypertension

    Nov 1, 2015, 00:00
  • When “Alive After 5 Years” Does Not Mean “Cured”- International Patterns In Cancer 10- To 20- Year Relative Survival Rates

    Nov 1, 2015, 00:00
  • Effectiveness and Side Effects of Oseltamivir for Influenza Treatment- A Meta-Analysis of Meta-Analysis

    Nov 1, 2015, 00:00
  • Experiences with Price Competition of Biosimilar Drugs In Hungary in Case of Colony-Stimulating Factor Products

    Nov 1, 2015, 00:00
  • Network Meta-Analysis for Health Technology Submissions Worldwide- A Report Checklist for Network Meta Analysis Best Practices Globally

    Nov 1, 2015, 00:00
  • Value Assessment and Pricing Frameworks for Rare Disease Treatments- New Approaches From The Literature

    Nov 1, 2015, 00:00
  • Validation of the English Version of the Forgotten Joint Score - 12 in Patients Undergoing Total Knee or Hip Arthroplasty

    Nov 1, 2015, 00:00
  • Evaluating Diabetes Patients’ Preferences for Profiles of Glp-1 Treatments In The United Kingdom- A Discrete Choice Experiment

    Nov 1, 2015, 00:00
  • Which Risk Share Agreements are Available and are Those Applied In Global Reimbursement Decisions?

    Nov 1, 2015, 00:00
  • Health Care Costs Associated With Geriatric Patients Diagnosed With Multiple Sclerosis Taking Disease Modifying Agents In The United States

    Nov 1, 2015, 00:00
  • Policy Implications of Affordable Care Act on Us Market Access

    Nov 1, 2015, 00:00
  • Review of Adherence Measures for use in Phase Iv Studies and Recommendations for a new Standardized Generic Measure

    Nov 1, 2015, 00:00
  • Network Meta-Analysis On Prevention Of Stroke For Patent Foramen Ovale Closure

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Analysis of Ponatinib In The Treatment of Chronic-Phase Chronic Myeloid Leukemia (Cp-Cml) In Sweden

    Nov 1, 2015, 00:00
  • The Nationwide Osmed Health-Db Database. A Tool To Support Healthcare Decision-Making And Real-World Evidence Generation

    Nov 1, 2015, 00:00
  • Comparison Of Comorbidity Measures To Predict Economic Outcomes In A Large Uk Primary Care Database

    Nov 1, 2015, 00:00
  • Cost-Utility Analysis of Insulin Analogues Compared with Multiple Daily Injections of Human Insulin for the Treatment of 15 Years Old or Older Patients with Type 1 Diabetes Mellitus in Colombia

    Nov 1, 2015, 00:00
  • Equity in Access to High Cost Drugs in Uruguay

    Nov 1, 2015, 00:00
  • The Actual Cost of a “Forced Switch” of Psychiatric Patients to a New Therapy- a Markov Chain – Monte Carlo Simulation

    Nov 1, 2015, 00:00
  • Determinação do Impacto Orçamentário no Modelo de Pagamento de Medicamentos Em Uma Operadora de Planos de Saúde- Buscando Novas Estratégias Para Minimizar Os Custos

    Nov 1, 2015, 00:00
  • Pharmacoeconomic Analysis of Ferric Carboxymaltose in Patients with Colon Cancer and Anemia

    Nov 1, 2015, 00:00
  • Hematological Toxicities Associated with Pazopanib use in Cancer Patients- A Meta-Analysis

    Nov 1, 2015, 00:00
  • Meses Evitados De Diálisis En Una Poblaci”N Con Enfermedad Renal Cr”Nica Estadio 5 Con Intervenci”N Predialítica En Colombia

    Nov 1, 2015, 00:00
  • Cost-Effectiveness of Incobotulinumtoxin-A With Flexible Treatment Intervals Compared to Onabotulinumtoxin-A In The Management of Blepharospasm And Cervical Dystonia

    Nov 1, 2015, 00:00
  • Economic Benefits Of Endometrial Radiofrequency Ablation Compared With Other Endometrial Ablation Techniques In Women With Menorrhagia- A Retrospective Analysis With German Health Claims Data

    Nov 1, 2015, 00:00
  • Re-Use Of Insulin Syringe Needles And Its Extra Disease Burden For Diabetic Patients In Beijing

    Nov 1, 2015, 00:00
  • Investigating The Impact of Structural Changes In A Nice Single Technology Appraisal Cost-Effectiveness Model

    Nov 1, 2015, 00:00
  • Economic Evaluation Of A Pharmacogenomic Test For Statin-Induced Myopathy In Cardiovascular High-Risk Patients Initiating A Statin

    Nov 1, 2015, 00:00
  • Resource And Cost Savings Due To Subcutaneous Versus Intravenous Administration Of Oncology Therapies- Case Studies With Rituximab (Mabthera) And Trastuzumab (Herceptin)

    Nov 1, 2015, 00:00
  • Stimulant Use and Cardiovascular Risk Among Children And Adolescents With Adhd- What Product Labeling Does, or Does Not, Tell Us

    Nov 1, 2015, 00:00
  • A Next-Generation Framework- Deciding On The Role Of Costs In The Clinical Use Of Targeted Gene Panels, Exome And Genome Sequencing

    Nov 1, 2015, 00:00
  • Valuation of Patient Satisfaction With Pharmaceutical Care As A Tool For Increasing Quality Management In Community Pharmacy And Patient’s Quality Of Life

    Nov 1, 2015, 00:00
  • Vedolizumab In Crohn’s Disease; A Budget Impact Model for A Novel Drug In A Recession Environment

    Nov 1, 2015, 00:00
  • UNDERSTANDING THE RELATIONSHIP BETWEEN HEALTH ASSESSMENT QUESTIONNAIRE-DISABILITY INDEX (HAQ-DI), PSORIASIS AREA SEVERITY INDEX (PASI), AND QUALITY OF LIFE (QOL) AND ITS INFLUENCE ON COST-EFFECTIVENESS IN PSORIATIC ARTHRITIS (PSA)

    Nov 1, 2015, 00:00
  • Timed Automata Modeling of The Personalized Treatment Decisions In Metastatic Castration Resistant Prostate Cancer

    Nov 1, 2015, 00:00
  • Cost-Utility of Omalizumab Compared With Standard of Care for The Treatment of Chronic Spontaneous Urticaria (Csu)

    Nov 1, 2015, 00:00
  • Pharmacoeconomic Analysis of Treatment Patients With Craniocerebral Injury In Ukraine

    Nov 1, 2015, 00:00
  • Atc1 Group Discount Distribution Analysis of Original Medicines Which Has No Generics In Turkey

    Nov 1, 2015, 00:00
  • Costo-Efectividad De La Cuantificaci”N De La Actividad Enzimática En Leucocitos En Comparaci”N A Su No Realizaci”N Para La Confirmaci”N Diagn”Stica De La Mucopolisacaridosis Tipo Iva En Colombia

    Nov 1, 2015, 00:00
  • Efficacy of The Mica Antibody for Transplant Patients

    Nov 1, 2015, 00:00
  • Does use of calcium channel blockers affect the risk of incident active tuberculosis disease? A nested case control study on a national health claim database

    Nov 1, 2015, 00:00
  • Adverse Drug Reactions, Medication Adherence and Physicians’ Prescribing Behavior- Which Relationship? a Database Analysis on Statin use

    Nov 1, 2015, 00:00
  • Effectiveness of A Referral Program for Early Arthritis Diagnosis At Primary Care Centers in Portugal - Preliminary Results from the Siara Study

    Nov 1, 2015, 00:00
  • The Cost Of Nutrition Alternatives For Premature Infants In The Neonatal Intensive Care Unit In Russia

    Nov 1, 2015, 00:00
  • The Epipen4schools® Survey- Staff Training And Use Of Epinephrine Auto-Injectors For The Treatment Of Anaphylaxis In Large Us School Districts

    Nov 1, 2015, 00:00
  • Assessing the Cost-Effectiveness of Antiretroviral Treatments in Hiv- an Individual Patient Simulation Approach

    Nov 1, 2015, 00:00
  • The Cost-Effectiveness Of Regorafenib In The Treatment Of Metastatic/Inoperable Gastrointestinal Stromal Tumors In Turkey

    Nov 1, 2015, 00:00
  • Review and Comparison of Eq-5d-3l Valuation Studies

    Nov 1, 2015, 00:00
  • Increased Costs Due To Myocardial Infarction (Mi) In Fran An Observational Analysis Using A Claims Database

    Nov 1, 2015, 00:00
  • Intravitrael Aflibercept Injection for The Treatment of Visual Impairment Due to Macular Oedema Secondary to Branch Retinal Vein Occlusion- Cost-Effectiveness Versus Ranibizumab

    Nov 1, 2015, 00:00
  • Clinical Pathway And Health Care Resources Utilization Of A Patients Cohort At High Risk Of Cardiovascular Disease Of Local Healthcare Unit (Asln°1) Of Milan- A Results Of Intervention On Secondary Prevention

    Nov 1, 2015, 00:00
  • International Comparison of Internet Information Source in Breast Cancer

    Nov 1, 2015, 00:00
  • The german nice or the german nasty? an analysis of iqwig decisions and requirements for an ‘added benefit'

    Nov 1, 2015, 00:00
  • Modelled U.K. And U.S. Analyses Demonstrate Sherlock 3cg® Tip Confirmation System For Peripherally Inserted Central Catheter Placement Is Associated With Favourable Health Economic Outcomes

    Nov 1, 2015, 00:00
  • Impact Of Her2 Testing Quality Improvement From A Health Economic Perspective

    Nov 1, 2015, 00:00
  • Building Intentions with The Theory of Planned Behaviour- A Qualitative Assessment of Salient Beliefs About Pharmacy Value Added Services in Malaysia

    Nov 1, 2015, 00:00
  • Systematic Literature Review And Critical Appraisal Of The Suitability Of The Outcome Measures Used In The Idiopathic Pulmonary Fibrosis

    Nov 1, 2015, 00:00
  • The Effectiveness Of Wide Field Fluorescein Angiography - Systematic Reviews

    Nov 1, 2015, 00:00
  • Pharmacoeconomic Analysis of Different Strategies of Replacement Therapy In Russian Patients With Pancreatic Exocrine Insufficiency

    Nov 1, 2015, 00:00
  • Survey of the Hungarian Physiotherapists’ Migration and Career Changing Behaviour

    Nov 1, 2015, 00:00
  • Comparative Effectiveness Using A Matching-Adjusted Indirect Comparison Between Delayed-Release Dimethyl Fumarate and Fingolimod for The Treatment of Relapsing-Remitting Multiple Sclerosis

    Nov 1, 2015, 00:00
  • Cost of Early Retirement Caused By Rheumatic Diseases In Portugal

    Nov 1, 2015, 00:00
  • Estimating Seasonal Allergic Conjunctivitis Market Size And Spending

    Nov 1, 2015, 00:00
  • Budget Impact Analysis of Implementing Tenders Between The Branded Infliximab And Its Biosimilars In The Public Hospitals of Paris

    Nov 1, 2015, 00:00
  • Análisis De Costo Efectividad Del Uso De Sorafenib En Pacientes Con Carcinoma Hepatocelular En Estadios Avanzados, Para El Contexto Ecuatoriano

    Nov 1, 2015, 00:00
  • A Systematic Literature Review of Risk Prediction Models for Mortality, Complications and Diabetes Outcomes After Bariatric Surgery

    Nov 1, 2015, 00:00
  • Examining the Economic Burden and Health Care Utilization of Menopausal Women in the U.S. Medicaid Population

    Nov 1, 2015, 00:00
  • An Analysis of Diabetic Medicine Utilization In Turkey

    Nov 1, 2015, 00:00
  • An Open Label, One Arm Study To Evaluate The Efficacy And Safety of Cerebrolysin In Patients With Acute Severe Ischemic Stroke In Mexico

    Nov 1, 2015, 00:00
  • The Effectiveness of Cbl Gene Mutation Test for Diagnosis In Juvenile Myelomonocytic Leukemia- Systematic Reviews

    Nov 1, 2015, 00:00
  • Does China’s New Medical Reform Improve Health Equity Of Rural Residents? Evidence From Household Surveys Before And After The Implementation Of New Medical Reform In Shaanxi Province, China

    Nov 1, 2015, 00:00
  • Costs Associated With Patients Diagnosed With Relapsing Remitting Multiple Sclerosis Taking Once Daily Fingolimod Capsules In The United States

    Nov 1, 2015, 00:00
  • Impacto Orçamentário do Everolimo e Sirolimo para Imunossupressão em Transplantados Hepáticos no Sistema Público de Saúde do Brasil

    Nov 1, 2015, 00:00
  • Cost-Effectiveness of New Therapies for Multiple Sclerosis In Spain

    Nov 1, 2015, 00:00
  • Real-World Treatment Patterns of Ranibizumab Among Patients With Retinal Diseases In Canada- 5 Years Of Data

    Nov 1, 2015, 00:00
  • Evolution of Treatment Paradigms In Metastatic Castrate-Resistant Prostate Cancer

    Nov 1, 2015, 00:00
  • Reduction of Complications and Associated Costs for Type 2 Diabetic Patients Using Continuous Subcutaneous Insulin Infusion In The Uk

    Nov 1, 2015, 00:00
  • Have Infliximab Discounted Prices in Norway Had an Impact on Prices Around the World?

    Nov 1, 2015, 00:00
  • Exploring the Use of Value of Information Methods to Prioritise Research to Address the Treatment Uncertainties Identified By the James Lind Alliance Priority Setting Partnerships

    Nov 1, 2015, 00:00
  • Differences Between The Efficacy of Biosimilars and Originators - Analysis and Implications for The Cost-Effectiveness-Analysis From A Payers Perspective

    Nov 1, 2015, 00:00
  • Migration of the Fatigue Symptoms and Impacts Questionnaire–Relapsing Multiple Sclerosis (Fsiq-Rmstm) from Paper to an Electronic Diary Format

    Nov 1, 2015, 00:00
  • The Assessment Of Value For Medical Devices- A Case Study On Injection Technique Education In Insulin Delivery

    Nov 1, 2015, 00:00
  • Prevalence Of Sleeping Pills Consumption And Its Association With Depressive Symptoms

    Nov 1, 2015, 00:00
  • Clinical And Economic Analysis Of Effectiveness Of Fondaparinux Sodium In The Treatment Of Acute Coronary Syndrome

    Nov 1, 2015, 00:00
  • Patient Characteristics and Health Care Resource Utilization of Patients Diagonsed with Neoplasm of Colon

    Nov 1, 2015, 00:00
  • Health States Worse Than Dead In An Elderly Population – Prevalence and The Significance of Chronic Pain

    Nov 1, 2015, 00:00
  • Contraception Patterns In Brazil- 2012 National Survey Data

    Nov 1, 2015, 00:00
  • Cognitive Debriefing And Usability Assessment Of The Eortc Qlq-C30 And Qlq-Br23 As Presented On Tablet And Handheld Devices

    Nov 1, 2015, 00:00
  • Análise De Custo-Utilidade Em Pacientes Com Insuficiência Renal Crônica Submetidos À Terapia Renal Substitutiva (Trs)

    Nov 1, 2015, 00:00
  • Applying Karnofsky Performance Scale In Hospitalized Patients For Promoting Rational Therapy

    Nov 1, 2015, 00:00
  • Estimating the Impacts of Medication Adherence and Persistence on Costs and Hospitalization- the Case of Atypical Antipsychotics

    Nov 1, 2015, 00:00
  • What Is Ce Marking? How Technologies Are Classified, And How To Navigate The System

    Nov 1, 2015, 00:00
  • Cost Analysis in Implementing Rituximab for non-Hodgkins Lymphoma - Intravenously and Subcutaneously - in Patients with Social Coverage in Latam

    Nov 1, 2015, 00:00
  • Hllkj

    Nov 1, 2015, 00:00
  • A Quantitative Analysis of Ten Health Technology Assessment (Hta) Agencies for Attributes Driving Transparency of the Organization

    Nov 1, 2015, 00:00
  • Characteristics of Patients with Relapsing Remitting Multiple Sclerosis Taking once Daily Teriflunomide Tablets in the United States

    Nov 1, 2015, 00:00
  • Evaluaci”N De Costo-Efectividad De La Implementaci”N De Monitoreo Ambulatorio De Presi”N Arterial Versus Perfil De Presi”N Arterial Para El Diagn”Stico De Hipertensi”N En El Sistema Público Chileno

    Nov 1, 2015, 00:00
  • The Cost-Effectiveness of Canagliflozin (CANA) Versus Dapagliflozin (Dapa) 10mg and Empagliflozin (EMPA) 25mg in Patients with Type 2 Diabetes Mellitus (T2DM) as Monotherapy in the United Kingdom

    Nov 1, 2015, 00:00
  • Controlling the Cost Spent on Expensive Biologic Agents- an Example of Net Monetary Savings By Dose Optimisation of Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis Patients

    Nov 1, 2015, 00:00
  • Bayesian Econometric Modelling Of Observational Data For Cost-Effectiveness Analysis

    Nov 1, 2015, 00:00
  • Construction Of Simulation Techniques For Development Of Optimal Cervical Cancer Screening Strategies- Experience Of Ukraine

    Nov 1, 2015, 00:00
  • Cost-Utility Analysis of Continuous Infusion Pump With Integrated Monitoring Compared With Multiple Daily Injection Treatment for Patients 15-Years or Older With Type 1 Diabetes Mellitus In Colombia

    Nov 1, 2015, 00:00
  • Contrasting Predictions of Cardiovascular Incidence Derived From Alternative Risk Prediction Models In Type 1 Diabetes

    Nov 1, 2015, 00:00
  • The Economic Consequences Of The Use Of Antibiotics In Belgium

    Nov 1, 2015, 00:00
  • Economic Burden and Quality of Life of Moderate-To-Severe Irritable Bowel Syndrome With Constipation (Ibs-C) In Germany- Results From The Ibis-C Study

    Nov 1, 2015, 00:00
  • The Cost-Effectiveness Analysis of Philips Motiva Telehealth System- A Comparison Between Home Telemonitoring, Nurse Telephone Support And Usual Care In Chronic Heart Failure

    Nov 1, 2015, 00:00
  • Generalized Implementation of Em Algorithm for Estimation of Transition Probability Matrix

    Nov 1, 2015, 00:00
  • Real World Data- Biologic Treatment for Naive Patient in the Lazio Region

    Nov 1, 2015, 00:00
  • Evaluation of The Effect of Crude Leaves Extract of Indigofera Spicata Forssk.(Fabaceae) on Blood Glucose Level of Normoglycemic, Oral Glucose Loaded and Alloxan Induced Diabetic Rodents

    Nov 1, 2015, 00:00
  • Role Of Pharmacoeconomic Analysis In Pricing Decision In Japan

    Nov 1, 2015, 00:00
  • The Burden of Moderate-To-Severe Irritable Bowel Syndrome With Constipation (Ibs-C) In Fran A Comparison With The European Results From The Ibis-C Observational Study

    Nov 1, 2015, 00:00
  • Assessment of Direct Cost for Treatment of Influenza and Ari for Outpatient In Ukraine

    Nov 1, 2015, 00:00
  • Evaluation of Inpatients’satisfaction in Pafos General Hospital, Cyprus

    Nov 1, 2015, 00:00
  • Hunting For Randomised Controlled Trials (Rcts)- A Comparison Of Search Filters Designed To Identify Rcts

    Nov 1, 2015, 00:00
  • Simulating Individual Patient Level Data Using An Illness-Death Modelling Framework In Order to Adjust for Treatment Switching When Only Summary Data Are Available

    Nov 1, 2015, 00:00
  • A Cost-Effectiveness Evaluation Comparing Biosimilar Bemfola to Gonal-F for the Treatment of Infertility in an Italian Contest

    Nov 1, 2015, 00:00
  • Budget Impact Analysis Of Tripliam For The Treatment Of Hypertension In Italy

    Nov 1, 2015, 00:00
  • A Method Based on the Remaining Value of Perfect Information for the Sample Size Calculation in Randomized Trial-Based Cost-Effectiveness Analyses

    Nov 1, 2015, 00:00
  • Real-World Hepatitis C Treatment Strategies in Denmark

    Nov 1, 2015, 00:00
  • Atrial Fibrillation And Anti-Coagulation Service Run By A Clinical Nurse Specialist

    Nov 1, 2015, 00:00
  • Budget Impact Analysis of Blood Clotting Factor Concentrates In The Treatment of Von Willebrand Disease

    Nov 1, 2015, 00:00
  • Device Inhalators In Asthma and Their Impact on Treatment Adherence

    Nov 1, 2015, 00:00
  • Pilot Assessment Of Pharmaceuticals Based On The Eunethta Core Model For Rapid Relative Effectiveness Assessment

    Nov 1, 2015, 00:00
  • Trends in Non-Submissions in the UK

    Nov 1, 2015, 00:00
  • How Pricing And Reimbursement Policies Affect The Budget Impact of The Treatment of Systemic Juvenile Idiopathic Arthritis In Turkey

    Nov 1, 2015, 00:00
  • Cost Of Genome Analysis- The Sanger Sequencing Method

    Nov 1, 2015, 00:00
  • Development of an Eq-5d Respiratory Bolt-on

    Nov 1, 2015, 00:00
  • Improved Survival With Ipilimumab In Patients With Advanced Melanoma In Real-World Clinical Practi First Results Of The Dutch Melanoma Treatment Registry

    Nov 1, 2015, 00:00
  • Students’ Knowledge and Perceptions Towards Quality Use of Medicines- A Descriptive Analysis From Universiti Sains Malaysia

    Nov 1, 2015, 00:00
  • Budget Impact Analysis Of Bioabsorbable Drug-Eluting Sinus Implants For Endoscopic Sinus Surgery

    Nov 1, 2015, 00:00
  • Monitored Cognitive Debriefing Interviews- a Case Study

    Nov 1, 2015, 00:00
  • Revision Sistemática De Estudios De Costo Efectividad De Intervenciones Sanitarias Para La Cesacion Del Hábito Tabáquico

    Nov 1, 2015, 00:00
  • Biologics In Ulcerative Colitis (Uc)- Treatment Guidelines and Health Technology Assessments (Hta)

    Nov 1, 2015, 00:00
  • Prediction Model for Functional Status at Discharge Following Rhabilitation After Intracerebral Hemorrhage

    Nov 1, 2015, 00:00
  • The Budget Impact Analysis of Adjunctive Therapy for Patients With Partial Epilepsy

    Nov 1, 2015, 00:00
  • A Review of Patient Registries in Heart Failure Across European Union-5 Countries

    Nov 1, 2015, 00:00
  • How to Determine The Target Population In Early Benefit Assessments In Germany? The Case of Diabetes Mellitus Type 2

    Nov 1, 2015, 00:00
  • Italian Healthcare Expenditure Trends From 2002 To 2013

    Nov 1, 2015, 00:00
  • Pharmacoeconomic Analysis Of The Combined Homocysteine-Lowering And Standard Therapy Versus Standard Therapy Of Patients With Chd, Postpercutaneous Coronary Intervention (Pci) And B12 Deficiency

    Nov 1, 2015, 00:00
  • Multi European Country Cost Consequence Comparison Of Floseal Matrix And Surgiflo Thrombin In Major And Severe Spine Surgeries

    Nov 1, 2015, 00:00
  • The Trends In Orphan Drug Authorisation and Approval In Europe And In The United States - A Retrospective Study (2005-2014)

    Nov 1, 2015, 00:00
  • The Indirect Costs of Multiple Sclerosis Associated With Absenteeism In Poland In 2013

    Nov 1, 2015, 00:00
  • Screening Guidelines And Cancer Stage- Early Findings From Medicare

    Nov 1, 2015, 00:00
  • Cost Analysis of Voriconazole Versus Liposomal Amphotericin B for Primary Therapy of Invasive Aspergillosis among High-Risk Hematologic Cancer Patients in Brazil

    Nov 1, 2015, 00:00
  • Cost-Effectiveness of Ceritinib Versus Current Therapies for Chemotherapy-Experienced Anaplastic Lymphoma Kinase Positive Non-Small Cell Lung Cancer Patients in Mexico

    Nov 1, 2015, 00:00
  • Validation Of The Overactive Bladder Questionnaire (Oab-Q; 1-Week Recall) In Medically Complex Elderly Adults With Overactive Bladder

    Nov 1, 2015, 00:00
  • Quality Of Life In Women Patients With Urinary Incontinence In Slovakia

    Nov 1, 2015, 00:00
  • Closing The Financial Gap of Antiretroviral and Hiv Supplies For Sustainability of Hiv National Response In The Dominican Republic

    Nov 1, 2015, 00:00
  • Costs Of Compression Therapy In Venous Leg Ulcers In Germany And Modelling Of The Economic Effects Of Regional Disparities In Health Care

    Nov 1, 2015, 00:00
  • Cost of Illness Analysis in Patients with Diabetic Foot Syndrome in Health Care of Republic of Belarus

    Nov 1, 2015, 00:00
  • The Value of Achieving Complete or Near Complete Resolution of Psoriasis

    Nov 1, 2015, 00:00
  • An Analysis of German G-BA Added Benefit Assessment Decisions Using the World Health Organization Daly Framework

    Nov 1, 2015, 00:00
  • Clinical Characteristics and Patterns of Care Among Patients With Genotype 1 (G1) Hepatitis C Virus In Europe (Eu)

    Nov 1, 2015, 00:00
  • French Physician Sensitivity To And Consideration Of The Costs Of Cancer Treatment

    Nov 1, 2015, 00:00
  • General Assessment Of Unlicensed Medicine Usage In Turkey

    Nov 1, 2015, 00:00
  • Are Spanish Regions Implementing The National Therapeutic Positioning Report (Tpr) Regarding New Oral Anticoagulants (Noac) In The Same Way? A Case Of Regional Variability In Drug Access

    Nov 1, 2015, 00:00
  • The Economic Value Proposition of Hand-Sewn Suture Versus Stapled Anastomoses During Right Colon Surgery

    Nov 1, 2015, 00:00
  • Impact of Genetic Factors on Gastrointestinal Bleeding in a Prospective Cohort of new Warfarin users

    Nov 1, 2015, 00:00
  • Prescription Pattern of Outpatient Department of A Teaching Hospital Quetta, Pakistan

    Nov 1, 2015, 00:00
  • The Comparative Pharmacoeconomic Analysis Of Using Plerixafor For Stem Cell Mobilization For Autologous Peripheral Stem Cell Transplantation For Non-Hodgkin’s Lymphoma Patients

    Nov 1, 2015, 00:00
  • Impact of Indiscriminate Use of Pump Infusion Set (Pis) on the Cost of Chemotherapy Treatments- A Cost Minimization Study

    Nov 1, 2015, 00:00
  • How are Pain Treatment Response Rates In Primary Care Influenced By Co-Prescription of Cyp2d6 Inhibitors?

    Nov 1, 2015, 00:00
  • A One-Year Follow-Up of Individuals with Diabetes at Very High Cv Risk Treated With Statins- Outcomes and Health Care Costs

    Nov 1, 2015, 00:00
  • Potential Long-Term Cost Savings In Treatment of Naïve Hiv-Infected Patients With Rilpivirine/ Tenofovir/ Emtricitabine (Single Tablet Regimen) In The Russian Federation

    Nov 1, 2015, 00:00
  • Costo Efectividad De La Hemodiálisis En Los Prestadores De Servicios De Dos Aseguradoras A Través De La Evaluación De Indicadores Mínimos Para El Análisis De Resultados Clínicos De La Terapia Dialítica En Colombia

    Nov 1, 2015, 00:00
  • Structure Of Health-Related Direct Costs In Ukraine - The First Step Of Analysis

    Nov 1, 2015, 00:00
  • Clinical Responses and Improvements in Patient-Reported Outcomes are Associated with Increased Productivity in the Workplace and at Home in Axial Spondyloarthritis Patients Treated with Certolizumab Pegol

    Nov 1, 2015, 00:00
  • Economic Evaluation Of The Rotavirus Vaccination Among Children Under 5 Years Of Age In Switzerland

    Nov 1, 2015, 00:00
  • Son útiles los enfoques de separación de funciones y cadena de valor para mejorar la organización, regulación y acceso a medicamentos?

    Nov 1, 2015, 00:00
  • Cost Effectiveness Analysis of Ranibizumab Compared to Aflibercept and Laser Intervention In Treatment of Diabetic Macular Edema (Dme) In The Czech Republic

    Nov 1, 2015, 00:00
  • Meta-Analysis of Mortality In Adults, Newborns and Older Children With Bacterial Infections And Sepsis When Treated By Igm-Enriched Intravenous Immunoglobulins And Standard Schemes

    Nov 1, 2015, 00:00
  • Hospitalization Costs of Type 2 Diabetes Mellitus (T2dm) Patients In A Public Hospital In Brazil

    Nov 1, 2015, 00:00
  • Access to Healthcare Among International Immigrants in Chile- Repeated Cross-Sectional Analysis of Casen Survey 2006-2009-2011

    Nov 1, 2015, 00:00
  • Reimbursement and Pricing of Innovative Medicines- EU5 Policies and Implications for Market Access

    Nov 1, 2015, 00:00
  • Budget Impact Analysis of Apremilast In Patients With Psoriatic Arthritis In Spain

    Nov 1, 2015, 00:00
  • Therapeutic and Economic Value of Everolimus Plus Exemestane for the Treatment of Postmenopausal Women with Hormone Receptor-Positive, Her2/Neu Negative Advanced Breast Cancer

    Nov 1, 2015, 00:00
  • Predictors of 10-Year Mortality After Primary Femoral Neck Fracture In Elderly Patients

    Nov 1, 2015, 00:00
  • Impact of Drug’s Presentation on Patients’ Perception of Treatment’s Risks Benefits Through New Ordinal Gee Modelling Method- Results from Imi Protect Wp6

    Nov 1, 2015, 00:00
  • Gender Differences in Medication Taking Behaviour- A Case of Osteoporosis

    Nov 1, 2015, 00:00
  • Economic Evaluation of Fecal Microbiota Transplantation for The Treatment of Recurrent Clostridium Difficile Infection In Australia

    Nov 1, 2015, 00:00
  • The Quality Of Life In Patients 12 Months After An Acute Coronary Syndrom- Results From The Pgrx-3 Real World Dataset

    Nov 1, 2015, 00:00
  • Causes And Cost Impact Of Variabilities On The AE Ward Utilization Across Hospitals In Spain

    Nov 1, 2015, 00:00
  • The Relative Clinical and Economic Value of Ipilimumab in the Treatment of Metastatic Melanoma Versus Other Anti-Cancer Agents for Metastatic Diseases from a Brazilian Private Health Care System Perspective

    Nov 1, 2015, 00:00
  • Defibrotide in Veno-Occlusive Disease in Public Hospitals of Paris- Funding Issues and Perspectives

    Nov 1, 2015, 00:00
  • Using Incentives to Improve Health-Related Behaviours- A Review of Incentive-Based Trials

    Nov 1, 2015, 00:00
  • Understanding Key Drivers of Successful Hta Submission — Developing a Model

    Nov 1, 2015, 00:00
  • Comparação De Tratamentos Para Câncer De Cabeça E Pescoço Ajustado Por Escore De Propensão- Radioterapia Versus Cirurgia+Radioterapia

    Nov 1, 2015, 00:00
  • Valuation of Eq-5d Health States by Pharmacy Students in Poland (Comparison of Different Methods and with General Population)

    Nov 1, 2015, 00:00
  • Reimbursement of Orphan and Expensive Drugs In The Netherlands- Exploration of Essential Criteria In The Decision Making Process

    Nov 1, 2015, 00:00
  • Published Diagnostic Discordance Of Lymphoma And Potential For Impact On Patient Care

    Nov 1, 2015, 00:00
  • The Oxford Participation Activities Questionnaire (Ox-Paq)- Psychometric Analysis

    Nov 1, 2015, 00:00
  • Effects Of Adverse Events On Quality Of Life Scores In A Randomized Clinical Trial Of Adjuvant Chemotherapy For Breast Cancer- N-Sas Bc 02

    Nov 1, 2015, 00:00
  • Patient Heterogeneity In Cost-Effectiveness Models for Chronic Obstructive Pulmonary Disease (Copd)- are Current Models Suitable to Evaluate Personalized Medicine

    Nov 1, 2015, 00:00
  • Tea Consumption and Health-Related Quality of Life In Elderly Adults

    Nov 1, 2015, 00:00
  • Diagnosis And Management of Moderate-To-Severe Irritable Bowel Syndrome With Constipation (Ibs-C) In Germany- Results From The Ibis-C Study

    Nov 1, 2015, 00:00
  • Comparison Between The Interim Eq-5d-5l Score And The New Japanese Scoring In Stroke Patients

    Nov 1, 2015, 00:00
  • Current Perception of Upcoming Cost-Effectiveness Requirements in Japan- a Survey on the Perspective of Pharmaceutical Industry

    Nov 1, 2015, 00:00
  • Assessing the Cost-Effectiveness of using Aclidinium Bromide 400 µG /Formoterol Fumarate Dihydrate 12 µG Compared to Aclidinium Bromide 400 µG in the Management of Moderate to Severe Chronic Obstructive Pulmonary Disease

    Nov 1, 2015, 00:00
  • Identifying The Optimal Use Of Ctcs In The Early Staging Phase Of Breast Cancer

    Nov 1, 2015, 00:00
  • Evaluation of the Burden of Opioid Abuse Among us Veteran Patients

    Nov 1, 2015, 00:00
  • Recent Update to Russia’s Essential Drugs List and Seven Nosologies- Clinical Differentiation And Local Manufacturing Implications for New Drug Inclusion

    Nov 1, 2015, 00:00
  • Patient Beliefs and Preferences in Treatment with Disease Modifying Anti-Rheumatic Drugs

    Nov 1, 2015, 00:00
  • Mammography For Breast Cancer Screening In India – A Health Technology Assessment

    Nov 1, 2015, 00:00
  • Life Quality of Young Adult Patients With Inflammable Bowel Disease

    Nov 1, 2015, 00:00
  • Promis® Physical Function Multilingual Translations- Progress And Outlook

    Nov 1, 2015, 00:00
  • Investigating The Value of Patient Level Data to Inform Estimates of Adpkd Progression Generated Within The Adpkd Outcomes Model

    Nov 1, 2015, 00:00
  • Using The Transtheoretical Model to Enhance Self-Management Activities In Type 2 Diabetic Patients- A Systematic Review

    Nov 1, 2015, 00:00
  • Do Access Restrictions Always Imply Cost Reduction? Case of Turkish Dpp4 Market In Treatment of Type Ii Diabetes

    Nov 1, 2015, 00:00
  • Estimating The Economic Consequences Of An Increased Medication Compliance Due To A Potential Improvement Of The Inhaler Technique With Spiromax® Compared With Turbuhaler® In Moderate To Severe Patients With Copd In Spain

    Nov 1, 2015, 00:00
  • Development Of An International Observational Study Programme To Describe The Management And Outcomes Of Mild Stroke And Transient Ischaemic Attack In Routine Clinical Practice

    Nov 1, 2015, 00:00
  • Heart Failure Management- A Nationwide Population-Based Cohort Study Using The French Egb Database

    Nov 1, 2015, 00:00
  • Anemia Treatment Cost in Patients with Chronic Kidney Disease (A-Ckd) In The Mexican Social Security Institute (Imss)

    Nov 1, 2015, 00:00
  • Economic Burden of Type 2 Diabetes Mellitus Treatment Strategies- A Cost Consequence Analysis of Sitagliptin vs Sulfonylureas in Lombardy Region

    Nov 1, 2015, 00:00
  • The Efficacy and Safety of Abatacept, Adalimumab, Etanercept And Tocilizumab are Comparable In Polyarticular Juvenile Idiopathic Arthritis

    Nov 1, 2015, 00:00
  • Shaping European Early Dialogues- The Seed Project

    Nov 1, 2015, 00:00
  • Sipuleucel-T (Provenge®)- Autopsy of an Innovative Change of Paradigm in Cancer Treatment

    Nov 1, 2015, 00:00
  • Irrational Drug Use Pattern In Hospitals. A Warning for Health Care System

    Nov 1, 2015, 00:00
  • Cost-Utility of Ranibizumab Versus Aflibercept for Treating Visual Impairment Due to Diabetic Macular Edema In Greece

    Nov 1, 2015, 00:00
  • Development of a Prediction Model of Disease Activity in Support of Clinical Practice – the Acrodat Experience

    Nov 1, 2015, 00:00
  • Rapid and Automated Test for Connectedness of Evidence Networks in Network Meta Analysis

    Nov 1, 2015, 00:00
  • Clinical and Economic Impact of Chronic Heart Failure in General Practi Analysis of 13.633 Patients

    Nov 1, 2015, 00:00
  • Analysis of Eribulin Mesylate Utilzation in Patients with Metastatic Breast Cancer (Mbc) by Line of Therapy and Associated Changes Over Time

    Nov 1, 2015, 00:00
  • An Assessment of the Impact of Biosimilars on Access to Biologics Based on Primary Research, System Dynamics Modelling, and War Gaming

    Nov 1, 2015, 00:00
  • Antibiotic Prescription Practices of Pediatricians In Hospital Care In Cyprus

    Nov 1, 2015, 00:00
  • Indicação Do Medicamento Talidomida Para O Tratamento De Mieloma Múltiplo- Uma Avaliação Para Atualização Da Rename

    Nov 1, 2015, 00:00
  • Value Assessment for Genetic Testing of Drug Variation In An Elderly Population

    Nov 1, 2015, 00:00
  • Use of Simulation to Assess the Impact of a Remote Monitoring System

    Nov 1, 2015, 00:00
  • Is Assignment of Financial Value Stimulating French Researchers of Paris Academic Hospitals to Publish in International Journals? Results of the Diazepam Survey

    Nov 1, 2015, 00:00
  • Systematic Literature Review of the Burden of Illness in Hypertriglyceridemia

    Nov 1, 2015, 00:00
  • The Impact Of Pharmaceutical Innovation On Premature Cancer Mortality In Portugal

    Nov 1, 2015, 00:00
  • Introduction of Formal Risk Sharing Agreements (Rsa)- A Promising Solution for Sustainable and Predictable Pharmaceutical Expenditures In Bulgaria

    Nov 1, 2015, 00:00
  • Rectal Culture Testing Before Transrectal Ultrasound-Guided Prostate Biopsy (Trusbx) In Hong Kong – A Cost-Effectiveness Analysis

    Nov 1, 2015, 00:00
  • Cost-Effectiveness and Cost-Utility Analyses Comparing Strategies for Initial Treatment of Rheumatoid Arthritis Using Published Outcomes- Economic Lessons From The Tear Trial

    Nov 1, 2015, 00:00
  • Analysis of Cost Minimization of Adalimumab Compared With Infliximab for The Treatment of Ulcerative Colitis In The Public Market In Mexico

    Nov 1, 2015, 00:00
  • The Cost of Vaccination Throughout Life- A Pan-European Perspective

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Of Bortizomib For Multiple Myeloma- A Systematic Review

    Nov 1, 2015, 00:00
  • Systematic Review and Cost-Effectiveness Analysis of Drug Used in Obesity Treatment in Brazil, Under Health System Perspective

    Nov 1, 2015, 00:00
  • Effects of Financial Incentives for Saving Drug Expenditures on Physician Prescription Behaviors

    Nov 1, 2015, 00:00
  • A One-Year Follow-Up of Patients with Acute Coronary Syndrome (Acs) and Diabetes Treated with Statins- Outcomes and Health Care Costs Supported by Italian National Health Service

    Nov 1, 2015, 00:00
  • The South African Guidelines for Pharmacoeconomic Submissions- A Review In Context of Existing Legislation and Challenges to Implementation

    Nov 1, 2015, 00:00
  • The Economics Of Critical Care Diagnostics- The Case Of Procalcitonin-Guided Care In Treatment Of Acute Respiratory Infection In The U.S

    Nov 1, 2015, 00:00
  • Extension of Indication With Mature Products- Toward More Incentives Rewarding Innovation?

    Nov 1, 2015, 00:00
  • Evaluación Del Costo-Efectividad Y Costo-Utilidad Del Uso De Rivaroxabán En Pacientes Con Fibrilación Auricular No Valvular Frente A Warfarina En El Contexto Ecuatoriano

    Nov 1, 2015, 00:00
  • Indirect Comparison for E/C/F/Taf In Treatment Naïve Hiv Patients

    Nov 1, 2015, 00:00
  • Evaluacion economica de tres terapias para la enfermedad pulmonar obstructiva cronica en chile. Análisis de costo utilidad

    Nov 1, 2015, 00:00
  • Towards Creating A National System of Care for Patients With Orphan Diseases

    Nov 1, 2015, 00:00
  • The Impact Of First-Line Tyrosine Kinase Inhibitors (Tkis) On Overall Survival In Patients With Advanced Non-Small Cell Lung Cancer (Nsclc) And Activating Epidermal Growth Factor Receptor (Egfr) Mutations- Meta-Analysis Of Major Randomized ...

    Nov 1, 2015, 00:00
  • The Increasing Cost Burden of Obesity Related Cancer to Nhs England

    Nov 1, 2015, 00:00
  • Sofosbuvir- The Failure of Pricing Policies In The European Union

    Nov 1, 2015, 00:00
  • Aspirin Versus Clopidogrel in Patients with Acute Myocardial Infarction- a Cost and Effectiveness Comparison from Beijing Medical Insurance Database

    Nov 1, 2015, 00:00
  • Economic Evaluation Of Fibrin Sealant Patch- A Proposal To Assess The Economic Value In Hemostasis And As A Surgical Sealant

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Of Sunitinib As Second-Line Treatment For Gastrointestinal Stromal Tumor(Gist) In China

    Nov 1, 2015, 00:00
  • Assessment of Health Related Quality of Life (Hrql) Using Eq-5d In Type 2 Diabetes Mellitus Patients In A University Teaching Hospital

    Nov 1, 2015, 00:00
  • Prevalence And Risk Factors Of Skin Cancer In Mexico- An Observational Study

    Nov 1, 2015, 00:00
  • Healthcare Associated Infections. Impact And Costs Of Diagnosis And Management Of Clostridium Difficile Infections (Cdi). The Experience Of A University Hospital In Rome

    Nov 1, 2015, 00:00
  • Resource Utilization Among Advanced Squamous and non-Squamous non-Small Cell Lung Cancer Patients Receiving Second-Line Treatment in France, Germany, Italy, and Spain- Results of A Retrospective Medical Chart Review

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Analysis of One-Piece Drainable Pouch Versus Two-Piece Drainable Pouch For Colostomates Under The Perspective of Patient’s Out-of-Pocket Expenses, In Brazil

    Nov 1, 2015, 00:00
  • Budget Impact Analysis of Delayed-Release Dimethylfumarate In The Treatment of Relapsing-Remitting Multiple Sclerosis In Italy

    Nov 1, 2015, 00:00
  • Quality Of Life And Emotional Impact Of A Fixed Dose Combination Of Antihypertensive Drugs In Patients With Uncontrolled Hypertension

    Nov 1, 2015, 00:00
  • «
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90 (current)
  • »